LOG IN
SIGN UP
MARKET
HAE
HAE
Haemonetics Corp Mass
NYSE
74.03
+0.42
+0.57%
After Hours: 74.03 0 0.00% 18:14 09/30 EDT
OPEN
73.92
PREV CLOSE
73.61
HIGH
75.81
LOW
73.49
VOLUME
351.91K
TURNOVER
0
52 WEEK HIGH
79.45
52 WEEK LOW
43.50
MARKET CAP
3.80B
P/E (TTM)
56.28
1D
5D
1M
3M
1Y
5Y
Here's Why Haemonetics (HAE) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks · 1d ago
Haemonetics (HAE) to Offer Two VASCADE Devices in the EU
Haemonetics' (HAE) VASCADE and VASCADE MVP devices help patients attain hemostasis more quickly and with lesser complications.
Zacks · 09/14 17:41
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
Benzinga · 09/12 22:29
BRIEF-Haemonetics Earns CE Mark For Vascade® Vascular Closure Product Portfolio
BRIEF-Haemonetics Earns CE Mark For Vascade® Vascular Closure Product Portfolio
Reuters · 09/12 10:45
Haemonetics Receives CE Mark for VASCADE Vascular Closure Products
Haemonetics Receives CE Mark for VASCADE Vascular Closure Products
MT Newswires · 09/12 08:09
Haemonetics (HAE) Business Recovery Continues, Macro Issues Ail
Despite sluggish results of Haemonetics' (HAE) Blood Center business, Whole Blood revenues grow on favorable order timing among distributors in the Asia Pacific and EMEA.
Zacks · 09/02 16:36
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks · 09/02 13:50
Are Investors Undervaluing Haemonetics Corporation (NYSE:HAE) By 27%?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Haemonetics...
Simply Wall St. · 09/01 11:04
About HAE
Haemonetics Corporation is a healthcare company. The Company provides a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Its segments include Plasma, Blood Center and Hospital. Its Plasma segment offers automated plasma collection and donor management software systems that improve the donor experience at plasma collection centers. Its Blood Center segment offers a range of solutions that improve donor collection centers' ability to acquire blood, filter blood and separate blood components. Its Hospital segment provides the patient care. It markets and sells its products to biopharmaceutical companies, blood collection groups and independent blood centers, hospitals and hospital service providers, group purchasing organizations and national health organizations.
Webull offers kinds of Haemonetics Corporation stock information, including NYSE:HAE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HAE stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading HAE stock methods without spending real money on the virtual paper trading platform.